In September 2025, South Korea’s rising beauty giant RIMAN achieved a breakthrough in the global skincare industry: securing a 20-year Plant Variety Protection (PVP) from the U.S. Department of Agriculture (USDA) for its proprietary Centella asiatica cultivar – Giant BYoungPool™.
This USDA approval isn’t just a technical victory; it represents a strategic leap. It ensures that RIMAN has exclusive cultivation and commercialization rights in the $150+ billion skincare market in the United States. With this recognition, RIMAN is well-positioned to disrupt global beauty trends, blending K-beauty innovation, biotechnology, and sustainability into one powerful package.
Founded in 2018 by KyungJung Kim, RIMAN began as a Korean startup with a bold mission: to redefine skincare through ingredient integrity, scientific validation, and a direct-selling model that empowers global distributors.
CEO KyungJung Kim envisioned skincare products that go beyond cosmetics—delivering dermaceutical efficacy. His philosophy, “From Root to Radiance,” emphasizes ingredient authenticity from cultivation to consumer.
Unlike traditional retail, RIMAN operates through a direct-selling (MLM-like) structure, where distributors, primarily women, act as brand ambassadors. This community-driven model has accelerated its penetration in markets like Korea, Malaysia, and the U.S.
Centella asiatica, known globally as “Gotu Kola” or “Cica,” has long been celebrated for its wound-healing and anti-aging properties. But RIMAN’s Giant BYoungPool™ is different:
Peer-reviewed studies (James et al., 2023; Choi et al., 2022) confirm that Centella’s compounds promote collagen synthesis and improve skin elasticity. Giant BYoungPool™, being richer in these compounds, positions RIMAN’s products in the cosmeceutical category, appealing to consumers seeking science-backed skincare.
In 2020, RIMAN established a Smart Farm in Jeju Island the world’s first facility exclusively dedicated to Centella Asiatica. Leveraging AI-driven sensors, climate control, and sustainable practices, this farm ensures year-round high-quality yields.
Unlike wild harvesting, smart farming guarantees purity, traceability, and scalability. This precision farming model aligns with global clean beauty trends, where consumers demand transparency in sourcing.
By securing 20-year exclusive rights, RIMAN prevents competitors from cultivating or marketing Giant BYoungPool™ in the U.S. This grants them a strong intellectual property moat, similar to a patent in biotechnology.
As highlighted by Nguyen & Zhao (2023), IP protection is a major hurdle in botanical cosmetics. RIMAN’s USDA-backed PVP ensures they stand apart from imitators, giving them a first-mover advantage in K-beauty’s global race.
With Halal certification, RIMAN positions itself strongly in Southeast Asia and the Middle East, where Muslim consumers seek ethical, permissible skincare.
ISO and clinical testing strengthen consumer trust in ICD products, ensuring safety, efficacy, and alignment with global dermatological standards.
In 2023, RIMAN rebranded Incellderm to ICD, creating a globally appealing identity. ICD is marketed as cosmeceuticals products at the intersection of cosmetics and pharmaceuticals.
Get more information
There are no reviews yet. Be the first one to write one.
